Stock listing
NASDAQ:NBSE NeuBase Therapeutics Inc Stock
Follow NeuBase Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:NBSE
$0.378 USD
Close on May 24, 2024 · No longer trades
- Lowest – highest close
- $0.378 – $3.050 USDSince Jun 15, 2023 · lowest May 10, 2024 · highest Jun 20, 2023
Delisted NASDAQ:NBSE no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:NBSE
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Eric I Richman Other companies: Gain Therapeutics, Inc. (Director · Since at least Mar 17, 2021); ADMA Biologics Inc (Director · Nov 9, 2017 – Feb 28, 2020 · Past) | Director · Jul 12, 2019 – Sep 9, 2022 · Past |
| Eric J Ende Other companies: Avadel Pharmaceuticals PLC (Director · Since at least May 27, 2022); Matinas BioPharma Holdings, Inc. (Director · Nov 14, 2022 – Nov 1, 2023 · Past) | Director · Sep 9, 2022 – Sep 9, 2022 · Past |
| Dietrich A Stephan | Founder and CEO, Director · Jul 12, 2019 – Aug 2, 2023 · Past |
| Gerald J McDougall | Director · May 11, 2021 – Sep 9, 2022 · Past |
| Irach B Taraporewala | Chief Executive Officer, Director · Jun 13, 2013 – Mar 10, 2015 · Past |
| William Roland Mann | Chief Operating Officer · Apr 26, 2021 – Mar 30, 2022 · Past |
Log in to ask 6ix AI your own questions about NeuBase Therapeutics Inc.